Cargando…

Can stellate ganglion blockage be an alternative treatment for refractory ventricular arrhythmias: Case series

Ventricular tachycardia (VT) and ventricular fibrillation (VF) are life-threatening conditions which increase in frequency over the years. Electrical storm (ES) is defined as the occurrence of 3 or more continuous ventricular arrhythmia. The sympathetic nervous system has an important role in Ventri...

Descripción completa

Detalles Bibliográficos
Autores principales: Küçükbingöz, Çağatay, Tepe, Ömer, Özmen, Çağlar, Özbek, Hayri T., Deniz, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313254/
https://www.ncbi.nlm.nih.gov/pubmed/37390263
http://dx.doi.org/10.1097/MD.0000000000034135
_version_ 1785067086346715136
author Küçükbingöz, Çağatay
Tepe, Ömer
Özmen, Çağlar
Özbek, Hayri T.
Deniz, Ali
author_facet Küçükbingöz, Çağatay
Tepe, Ömer
Özmen, Çağlar
Özbek, Hayri T.
Deniz, Ali
author_sort Küçükbingöz, Çağatay
collection PubMed
description Ventricular tachycardia (VT) and ventricular fibrillation (VF) are life-threatening conditions which increase in frequency over the years. Electrical storm (ES) is defined as the occurrence of 3 or more continuous ventricular arrhythmia. The sympathetic nervous system has an important role in Ventricular arrythmias (VA) and is the target of treatment. Studies show that stellate ganglion blockade (SGB) can reduce cardiac sympathetic tone and is an alternative bridge therapy in VAs. PATIENT CONCERNS: Among the patients who were admitted to the hospital with the complaints of general condition disorder and palpitation. DIAGNOSIS: Patients were referred to the Cardiology department and diagnosed VA and ES. Patients who applied to the Cardiology Department with the diagnosis of VA or ES and did not benefit from antiarrhythmic drug therapy were selected and evaluated by a team of 2 anesthesiologists (cardiothoracic and pain specialists) and 2 cardiologists (1 of whom is an electrophysiology specialist). INTERVENTION: In our study, ultrasound (USG) guided left SGB was applied to 10 VA and ES patients with implantable cardiac defibrillator (ICD). The 6-month results of the patients were evaluated retrospectively. For blockage, the solution was prepared by adding 8 mg dexamethasone, 40 mg lidocaine and 10 mg bupivacaine to 10 mL with physiological saline. The success of the procedure was evaluated with the development of Horner syndrome in the left eye. OUTCOMES: Resistant VA developed in 2 of 10 patients who had left SGB due to VF/VT ES and were excluded from the study. One (1) month after the procedure it was seen that there was a statistically significant decrease in the number of shocks in 8 patients in the 6th month controls compared to the pre-procedure. The number of VES in the 1st and 6th months of the patients was also statistically significantly decreased compared to the pre-SSD (P = .01, P = .01, P = .01, respectively). CONCLUSION: Unilateral USG-guided SGB application is an effective and safe method in patients with ES and VA. Long-term results can be satisfactory in successful responders in whom SGB is performed with a combination of local anesthetic and steroid.
format Online
Article
Text
id pubmed-10313254
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103132542023-07-01 Can stellate ganglion blockage be an alternative treatment for refractory ventricular arrhythmias: Case series Küçükbingöz, Çağatay Tepe, Ömer Özmen, Çağlar Özbek, Hayri T. Deniz, Ali Medicine (Baltimore) 3300 Ventricular tachycardia (VT) and ventricular fibrillation (VF) are life-threatening conditions which increase in frequency over the years. Electrical storm (ES) is defined as the occurrence of 3 or more continuous ventricular arrhythmia. The sympathetic nervous system has an important role in Ventricular arrythmias (VA) and is the target of treatment. Studies show that stellate ganglion blockade (SGB) can reduce cardiac sympathetic tone and is an alternative bridge therapy in VAs. PATIENT CONCERNS: Among the patients who were admitted to the hospital with the complaints of general condition disorder and palpitation. DIAGNOSIS: Patients were referred to the Cardiology department and diagnosed VA and ES. Patients who applied to the Cardiology Department with the diagnosis of VA or ES and did not benefit from antiarrhythmic drug therapy were selected and evaluated by a team of 2 anesthesiologists (cardiothoracic and pain specialists) and 2 cardiologists (1 of whom is an electrophysiology specialist). INTERVENTION: In our study, ultrasound (USG) guided left SGB was applied to 10 VA and ES patients with implantable cardiac defibrillator (ICD). The 6-month results of the patients were evaluated retrospectively. For blockage, the solution was prepared by adding 8 mg dexamethasone, 40 mg lidocaine and 10 mg bupivacaine to 10 mL with physiological saline. The success of the procedure was evaluated with the development of Horner syndrome in the left eye. OUTCOMES: Resistant VA developed in 2 of 10 patients who had left SGB due to VF/VT ES and were excluded from the study. One (1) month after the procedure it was seen that there was a statistically significant decrease in the number of shocks in 8 patients in the 6th month controls compared to the pre-procedure. The number of VES in the 1st and 6th months of the patients was also statistically significantly decreased compared to the pre-SSD (P = .01, P = .01, P = .01, respectively). CONCLUSION: Unilateral USG-guided SGB application is an effective and safe method in patients with ES and VA. Long-term results can be satisfactory in successful responders in whom SGB is performed with a combination of local anesthetic and steroid. Lippincott Williams & Wilkins 2023-06-30 /pmc/articles/PMC10313254/ /pubmed/37390263 http://dx.doi.org/10.1097/MD.0000000000034135 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 3300
Küçükbingöz, Çağatay
Tepe, Ömer
Özmen, Çağlar
Özbek, Hayri T.
Deniz, Ali
Can stellate ganglion blockage be an alternative treatment for refractory ventricular arrhythmias: Case series
title Can stellate ganglion blockage be an alternative treatment for refractory ventricular arrhythmias: Case series
title_full Can stellate ganglion blockage be an alternative treatment for refractory ventricular arrhythmias: Case series
title_fullStr Can stellate ganglion blockage be an alternative treatment for refractory ventricular arrhythmias: Case series
title_full_unstemmed Can stellate ganglion blockage be an alternative treatment for refractory ventricular arrhythmias: Case series
title_short Can stellate ganglion blockage be an alternative treatment for refractory ventricular arrhythmias: Case series
title_sort can stellate ganglion blockage be an alternative treatment for refractory ventricular arrhythmias: case series
topic 3300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313254/
https://www.ncbi.nlm.nih.gov/pubmed/37390263
http://dx.doi.org/10.1097/MD.0000000000034135
work_keys_str_mv AT kucukbingozcagatay canstellateganglionblockagebeanalternativetreatmentforrefractoryventriculararrhythmiascaseseries
AT tepeomer canstellateganglionblockagebeanalternativetreatmentforrefractoryventriculararrhythmiascaseseries
AT ozmencaglar canstellateganglionblockagebeanalternativetreatmentforrefractoryventriculararrhythmiascaseseries
AT ozbekhayrit canstellateganglionblockagebeanalternativetreatmentforrefractoryventriculararrhythmiascaseseries
AT denizali canstellateganglionblockagebeanalternativetreatmentforrefractoryventriculararrhythmiascaseseries